| 1 | [SID14718840] | Active | CC50 | 3.55e-06 | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) [AID1259, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | CC50 | 3.55e-06 [uM] | | BioAssay | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) | | AID | 1259 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID14718840] | Active | IC50 | 0.341 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 0.341 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 3 | [SID14718840] | Active | IC50 | 0.341 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 0.341 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 4 | [SID14718840] | Active | IC50 | 0.73 | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489035, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 0.73 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489035 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID14718840] | Active | Potency | 0.92 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 0.92 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID14718840] | Active | Potency | 1.0323 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID14718840] | Active | EC50 | 1.07 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast [AID2631, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 1.07 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast | | AID | 2631 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID14718840] | Active | Potency | 1.122 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID14718840] | Active | AC50 | 1.67 | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity [AID624133, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 1.67 [uM] | | BioAssay | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624133 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID14718840] | Active | EC50 | 1.77 | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity [AID435010, Type: confirmatory] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 1.77 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity | | AID | 435010 | | BioAssay type | confirmatory | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 11 | [SID14718840] | Active | AC50 | 1.831 | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity [AID449749, Type: confirmatory] | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 1.831 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity | | AID | 449749 | | BioAssay type | confirmatory | | Target | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] | | PubMed | | | Data Table |  |
|
| 12 | [SID14718840] | Active | AC50 | 1.88 | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity [AID624132, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 1.88 [uM] | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624132 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID14718840] | Active | IC50 | 2.16 | CHOP dose-response primary assay [AID504322, Type: confirmatory] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 2.16 [uM] | | BioAssay | CHOP dose-response primary assay | | AID | 504322 | | BioAssay type | confirmatory | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 14 | [SID14718840] | Active | EC50 | 2.702 | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast [AID1936, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 2.702 [uM] | | BioAssay | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast | | AID | 1936 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID14718840] | Active | EC50 | 2.741 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) [AID2382, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 2.741 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) | | AID | 2382 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 16 | [SID14718840] | Active | EC50 | 2.741 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) [AID2382, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 2.741 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) | | AID | 2382 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 17 | [SID14718840] | Active | AC50 | 2.769 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 2.769 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID14718840] | Active | Potency | 2.9093 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay [AID602204, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay | | AID | 602204 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID14718840] | Active | Potency | 3.1623 | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID14718840] | Active | Potency | 3.1623 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 21 | [SID14718840] | Active | EC50 | 3.27 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 3.27 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 22 | [SID14718840] | Active | EC50 | 3.27 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 3.27 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 23 | [SID14718840] | Active | IC50 | 3.35 | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) [AID504729, Type: confirmatory] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 3.35 [uM] | | BioAssay | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 504729 | | BioAssay type | confirmatory | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 24 | [SID14718840] | Active | EC50 | 3.625 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast [AID1934, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 3.625 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast | | AID | 1934 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID14718840] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 26 | [SID14718840] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 27 | [SID14718840] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 28 | [SID14718840] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 29 | [SID14718840] | Active | Potency | 3.6964 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6964 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID14718840] | Active | Potency | 3.6964 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.6964 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID14718840] | Active | IC50 | 3.752 | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1913, Type: confirmatory] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 3.752 [uM] | | BioAssay | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1913 | | BioAssay type | confirmatory | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 32 | [SID14718840] | Active | IC50 | 3.752 | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1913, Type: confirmatory] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 3.752 [uM] | | BioAssay | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1913 | | BioAssay type | confirmatory | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 33 | [SID14718840] | Active | IC50 | 3.752 | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1913, Type: confirmatory] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 3.752 [uM] | | BioAssay | Luminescence-based dose response biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1913 | | BioAssay type | confirmatory | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 34 | [SID14718840] | Active | Potency | 3.9811 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 35 | [SID14718840] | Active | Potency | 3.9811 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 36 | [SID14718840] | Active | Potency | 4.1095 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID14718840] | Active | AC50 | 4.129 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 4.129 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID14718840] | Active | IC50 | 4.38 | XBP1 DR counterscreen for CHOP [AID504313, Type: confirmatory] | XBP1 [Homo sapiens] [gi:47678753] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 4.38 [uM] | | BioAssay | XBP1 DR counterscreen for CHOP | | AID | 504313 | | BioAssay type | confirmatory | | Target | XBP1 [Homo sapiens] [gi:47678753] | | PubMed | | | Data Table |  |
|
| 39 | [SID14718840] | Active | IC50 | 4.43 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 4.43 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID14718840] | Active | EC50 | 4.654 | Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation [AID434968, Type: confirmatory] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | EC50 | 4.654 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation | | AID | 434968 | | BioAssay type | confirmatory | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 41 | [SID14718840] | Active | AC50 | 4.76 | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity [AID624134, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | AC50 | 4.76 [uM] | | BioAssay | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624134 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID14718840] | Active | Potency | 5.1735 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 43 | [SID14718840] | Active | IC50 | 5.39 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 5.39 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 44 | [SID14718840] | Active | IC50 | 5.39 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | IC50 | 5.39 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 45 | [SID14718840] | Active | Potency | 5.6234 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 46 | [SID14718840] | Active | Potency | 5.6234 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 47 | [SID14718840] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID14718840] | Active | Potency | 5.6234 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 49 | [SID14718840] | Active | Potency | 5.6234 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 50 | [SID14718840] | Active | Potency | 6.3096 | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14718840 | | CID | 6552076 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|